Regulatory Affairs Career Guide | Episode 02 - Kickstart Your Dream Career in Regulatory Affairs
PharmaCamp
Regulatory Affairs Career Guide | Episode 02 - Kickstart Your Dream Career in Regulatory Affairs
7:47
Regulatory Affairs Career Guide | Episode 01 - Top 09 Skills for Regulatory Professionals
PharmaCamp
Regulatory Affairs Career Guide | Episode 01 - Top 09 Skills for Regulatory Professionals
12:32
Drug Device Combination Products| Episode 08 - Dossier Requirements :Combination Products - US vs EU
PharmaCamp
Drug Device Combination Products| Episode 08 - Dossier Requirements :Combination Products - US vs EU
4:56
Drug Device Combination Products | Episode 07 - GMP Requirements for Combination Products - US vs EU
PharmaCamp
Drug Device Combination Products | Episode 07 - GMP Requirements for Combination Products - US vs EU
4:13
Drug Device Combination Products | Episode 06 - How to Select Notified Body in EU?
PharmaCamp
Drug Device Combination Products | Episode 06 - How to Select Notified Body in EU?
9:05
What is the CE mark for medical devices? #medicaldevices #combinationproducts #healthcareindustry
PharmaCamp
What is the CE mark for medical devices? #medicaldevices #combinationproducts #healthcareindustry
0:55
What is the Notified Body in the European Union ?#combinationproducts #medicaldevices#regulatory
PharmaCamp
What is the Notified Body in the European Union ?#combinationproducts #medicaldevices#regulatory
0:42
Drug Device Combination Products | Episode 05 -Notified Body Opinion in EU: Essential Steps (Part3)
PharmaCamp
Drug Device Combination Products | Episode 05 -Notified Body Opinion in EU: Essential Steps (Part3)
3:58
Drug Device Combination Products | Episode 04-Regulatory Procedure:Combination Products in EU Part-2
PharmaCamp
Drug Device Combination Products | Episode 04-Regulatory Procedure:Combination Products in EU Part-2
2:43
Drug Device Combination Products | Episode 03-Regulatory Procedure:Combination Products in EU Part-1
PharmaCamp
Drug Device Combination Products | Episode 03-Regulatory Procedure:Combination Products in EU Part-1
5:22
Purple Book vs Orange Book
PharmaCamp
Purple Book vs Orange Book
0:39
How to find the information on USFDA approved drug/biological products?
PharmaCamp
How to find the information on USFDA approved drug/biological products?
0:47
Drug Device Combination Products | Episode 02 - Regulatory Procedure for Combination Products in USA
PharmaCamp
Drug Device Combination Products | Episode 02 - Regulatory Procedure for Combination Products in USA
7:11
Drug Device Combination Products | Episode 01- What are the Regulations for Combination Products?
PharmaCamp
Drug Device Combination Products | Episode 01- What are the Regulations for Combination Products?
15:24
Wait is over!!! Next Series Announcement - Combination Products
PharmaCamp
Wait is over!!! Next Series Announcement - Combination Products
0:41
Orphan Drug Development | Episode 07 - How to get Orphan Drug Designation in Japan | MHLW | DRA
PharmaCamp
Orphan Drug Development | Episode 07 - How to get Orphan Drug Designation in Japan | MHLW | DRA
5:30
Orphan Drug Development | Episode 06 - USFDA vs EMA : Orphan Drug Designation | Regulatory Affairs
PharmaCamp
Orphan Drug Development | Episode 06 - USFDA vs EMA : Orphan Drug Designation | Regulatory Affairs
7:53
Orphan Drug Development | Episode 05 - How to get Orphan Drug Designation in USA | USFDA | DRA
PharmaCamp
Orphan Drug Development | Episode 05 - How to get Orphan Drug Designation in USA | USFDA | DRA
8:33
Orphan Drug Development | Episode 04 - How to get Orphan Drug Designation in European Union | DRA
PharmaCamp
Orphan Drug Development | Episode 04 - How to get Orphan Drug Designation in European Union | DRA
13:52
Orphan Drug Development | Episode 03- Benefits and Incentives for Orphan Drug Development | DRA
PharmaCamp
Orphan Drug Development | Episode 03- Benefits and Incentives for Orphan Drug Development | DRA
5:16
Orphan Drug Development | Episode 02- What is Orphan Drug Designation? | Drug Regulatory Affairs
PharmaCamp
Orphan Drug Development | Episode 02- What is Orphan Drug Designation? | Drug Regulatory Affairs
4:48
Orphan Drug Development | Episode 01- What is Orphan Drug? | Rare Disease | Drug Regulatory Affairs
PharmaCamp
Orphan Drug Development | Episode 01- What is Orphan Drug? | Rare Disease | Drug Regulatory Affairs
9:12
Dare to Lead with Neha | Episode 01- Karthik Ramani | An Interview Series with Pharma Leaders
PharmaCamp
Dare to Lead with Neha | Episode 01- Karthik Ramani | An Interview Series with Pharma Leaders
49:23
I am excited to announce the launch of a new YouTube series "𝗗𝗮𝗿𝗲 𝘁𝗼 𝗟𝗲𝗮𝗱 𝘄𝗶𝘁𝗵 𝗡𝗲𝗵𝗮."
PharmaCamp
I am excited to announce the launch of a new YouTube series "𝗗𝗮𝗿𝗲 𝘁𝗼 𝗟𝗲𝗮𝗱 𝘄𝗶𝘁𝗵 𝗡𝗲𝗵𝗮."
0:03
What are the Steps and Timelines for Decentralised Procedure and Mutual Recognition Procedure?| DRA
PharmaCamp
What are the Steps and Timelines for Decentralised Procedure and Mutual Recognition Procedure?| DRA
10:33
EU Marketing Authorisation | What are the Steps and Timelines for Centralised Procedure at EMA?| DRA
PharmaCamp
EU Marketing Authorisation | What are the Steps and Timelines for Centralised Procedure at EMA?| DRA
16:57
Regulatory Shorts#8 | How to get Marketing Authorisation in European Union (EU)? | Drug Registration
PharmaCamp
Regulatory Shorts#8 | How to get Marketing Authorisation in European Union (EU)? | Drug Registration
16:11
Regulatory Shorts#7 | Patent vs Data Exclusivity vs Market Exclusivity | Drug Regulatory Affairs
PharmaCamp
Regulatory Shorts#7 | Patent vs Data Exclusivity vs Market Exclusivity | Drug Regulatory Affairs
6:30
Regulatory Shorts#6 | Global Expedited Regulatory Pathways | Drug Regulatory Affairs
PharmaCamp
Regulatory Shorts#6 | Global Expedited Regulatory Pathways | Drug Regulatory Affairs
6:25
Regulatory Shorts#5| Side Effect vs Adverse Drug Reaction vs Adverse Event | Drug Regulatory Affairs
PharmaCamp
Regulatory Shorts#5| Side Effect vs Adverse Drug Reaction vs Adverse Event | Drug Regulatory Affairs
5:43
Regulatory Shorts#4 | Orange Book vs Purple Book | USFDA | Drug Regulatory Affairs
PharmaCamp
Regulatory Shorts#4 | Orange Book vs Purple Book | USFDA | Drug Regulatory Affairs
6:09
Regulatory Shorts#3 |Data Lock Point, International Birth Date, Development International Birth Date
PharmaCamp
Regulatory Shorts#3 |Data Lock Point, International Birth Date, Development International Birth Date
3:36
Regulatory Shorts#2 | DSUR vs PSUR | Safety Reports | Drug Regulatory Affairs
PharmaCamp
Regulatory Shorts#2 | DSUR vs PSUR | Safety Reports | Drug Regulatory Affairs
4:17
Regulatory Shorts#1 | COVID-19 Vaccine | Expanded Access vs Emergency Use Authorization vs Off-Label
PharmaCamp
Regulatory Shorts#1 | COVID-19 Vaccine | Expanded Access vs Emergency Use Authorization vs Off-Label
8:11
Step 9: Completion of Clinical Trial and Ending an IND | Regulatory Learnings | DRA
PharmaCamp
Step 9: Completion of Clinical Trial and Ending an IND | Regulatory Learnings | DRA
5:32
Step 8: How to do IND Life Cycle Management? | Regulatory Learnings| DRA
PharmaCamp
Step 8: How to do IND Life Cycle Management? | Regulatory Learnings| DRA
4:15
Step 7: How are Clinical Trials Registered in USA? | Regulatory Learnings
PharmaCamp
Step 7: How are Clinical Trials Registered in USA? | Regulatory Learnings
4:42
Step 6: How does USFDA review an Investigational New Drug (IND) application (Part 2)? | DRA
PharmaCamp
Step 6: How does USFDA review an Investigational New Drug (IND) application (Part 2)? | DRA
3:13
Step 6: How does USFDA review an Investigational New Drug (IND) application? | Regulatory Learnings
PharmaCamp
Step 6: How does USFDA review an Investigational New Drug (IND) application? | Regulatory Learnings
2:15
Step 5: How to submit an Investigational New Drug (IND) application to USFDA? | Regulatory Learnings
PharmaCamp
Step 5: How to submit an Investigational New Drug (IND) application to USFDA? | Regulatory Learnings
3:59
Step 4: Types of USFDA forms for IND application (Part 2)? | Regulatory Learnings | DRA
PharmaCamp
Step 4: Types of USFDA forms for IND application (Part 2)? | Regulatory Learnings | DRA
6:43
Step 4: What content do we include in IND application (Part 1)? | Regulatory Learnings | DRA
PharmaCamp
Step 4: What content do we include in IND application (Part 1)? | Regulatory Learnings | DRA
8:17
Step 3: 14 Tips to follow during and after USFDA Meeting (Part 5)? | Regulatory Learnings | DRA
PharmaCamp
Step 3: 14 Tips to follow during and after USFDA Meeting (Part 5)? | Regulatory Learnings | DRA
7:11
Step 3: 10 Tips For Preparation of Successful USFDA Meeting (Part 4)? | Regulatory Learnings | DRA
PharmaCamp
Step 3: 10 Tips For Preparation of Successful USFDA Meeting (Part 4)? | Regulatory Learnings | DRA
10:20
Step 3: What are the Steps for Meetings with USFDA (Part 3)? | Regulatory Learnings | DRA
PharmaCamp
Step 3: What are the Steps for Meetings with USFDA (Part 3)? | Regulatory Learnings | DRA
6:05
Step 3: What are the Types of USFDA Meetings (Part 2)? | Regulatory Learnings | DRA
PharmaCamp
Step 3: What are the Types of USFDA Meetings (Part 2)? | Regulatory Learnings | DRA
7:54
Step 3: Meetings with USFDA (Part 1) | Regulatory Learnings | Drug Regulatory Affairs
PharmaCamp
Step 3: Meetings with USFDA (Part 1) | Regulatory Learnings | Drug Regulatory Affairs
6:56
Step 2: What is Target Product Profile (TPP)? | Regulatory Learnings | Drug Regulatory Affairs
PharmaCamp
Step 2: What is Target Product Profile (TPP)? | Regulatory Learnings | Drug Regulatory Affairs
5:52
Step 1: How to prepare the Regulatory Strategies for IND Application? | Regulatory Learnings | DRA
PharmaCamp
Step 1: How to prepare the Regulatory Strategies for IND Application? | Regulatory Learnings | DRA
7:21
Step-wise Approach for Investigational New Drug (IND) Application? | Regulatory Learnings | DRA
PharmaCamp
Step-wise Approach for Investigational New Drug (IND) Application? | Regulatory Learnings | DRA
4:25
What is Investigational New Drug (IND) Application? | Regulatory Learnings | Drug Regulatory Affairs
PharmaCamp
What is Investigational New Drug (IND) Application? | Regulatory Learnings | Drug Regulatory Affairs
5:30
What is Clinical Trial? | Regulatory Learnings | Drug Regulatory Affairs
PharmaCamp
What is Clinical Trial? | Regulatory Learnings | Drug Regulatory Affairs
10:26
Welcome to PharmaCamp with Neha | Regulatory Learnings | Drug Regulatory Affairs
PharmaCamp
Welcome to PharmaCamp with Neha | Regulatory Learnings | Drug Regulatory Affairs
3:18